This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Drea, E. J. Search for Related Content Social Bookmarking                         What's this?

Transition of Products From Prescription to Over the Counter: The H2 Antagonists

Department of Pharmacy Services, Memorial Medical Center, Springfield, IL

In general, the histamine type-2 receptor antagonists (H₂RA) enjoy an enviable record of safety. These agents, notably cimetidine, have been studied extensively in clinical trials, case reports, and worldwide drug use reporting systems. Of the available agents (cimetidine, famotidine, nizatidine, and ranitidine) several similarities exist from compound to compound and use data to support that each of the agents is equally safe and efficacious in equipotent dosing. A review of H₂RA pharmacology, pharmacokinetics, adverse effects, and drug interactions is included to provide the clinician with a basis for rational selection and use of an H₂RA.

Journal of Pharmacy Practice, Vol. 5, No. 1, 22-30 (1992)
DOI: 10.1177/089719009200500106


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?